Intangible Assets

Kenvue owns globally recognized consumer health and personal care brands such as Tylenol, Neutrogena, Listerine, and Aveeno, which support shelf presence and some pricing power versus private label and smaller peers.

Brand equity is more durable in self-care categories where trust and habitual use matter, but it is less protective than prescription, device, or platform-based moats because consumers can still switch among branded alternatives.

Compared with peers like Haleon and P&G’s health-adjacent franchises, Kenvue’s brands are strong but generally narrower in category breadth and less able to command premium pricing across the full portfolio.

Regulatory and safety expectations in OTC health products raise the cost of brand damage, which reinforces trust-based intangibles, but this protection is shared by major peers and does not create clear structural exclusivity.

The moat from intangibles is real but not exceptional because brand strength supports retention and margins, yet it remains replicable over time through advertising, innovation, and retailer substitution.

Switching Costs

Kenvue sells mostly low-involvement consumer products, so end users face minimal economic or operational cost to switch to rival brands at the point of purchase.

Retailers can substitute shelf space among branded and private-label alternatives with limited friction, which keeps switching costs materially lower than in healthcare services, software, or industrial systems.

Compared with peers such as Haleon, Colgate-Palmolive, and P&G, Kenvue does not appear to benefit from contractual lock-in, workflow integration, or proprietary usage dependencies that would raise retention.

Habit and familiarity can reduce churn in some categories, but these are behavioral preferences rather than true switching costs and therefore provide only limited moat durability.

Because customers can readily trial alternatives without meaningful penalty, switching costs do not materially protect pricing power or margins over a 5–10 year horizon.

Network Effects

Kenvue’s consumer health and personal care products do not become more valuable as more users adopt them, so there is no meaningful direct network effect.

The company lacks platform dynamics, user-generated ecosystems, or data loops that would compound value relative to peers over time.

Retail distribution breadth can improve visibility, but that is a scale and access benefit rather than a network effect because one customer’s use does not increase another customer’s utility.

Compared with digital health, marketplaces, or software peers, Kenvue has no structural network-based advantage that would deepen retention or pricing power.

Any brand awareness spillover is indirect and too weak to qualify as a durable network effect.

Cost Advantage

Kenvue can benefit from large-scale procurement, manufacturing, and distribution across a portfolio of household brands, which can lower unit costs versus smaller branded competitors.

Its asset turnover and cash conversion cycle suggest reasonably efficient working-capital management, but these metrics indicate operational discipline rather than a hard structural cost edge.

Compared with P&G, Unilever, and Colgate-Palmolive, Kenvue likely has less diversified scale and fewer category synergies, which limits the durability of any cost advantage.

Private-label competitors can often undercut branded pricing on cost, so Kenvue’s cost position helps defend margins only when paired with brand trust and retailer execution.

The cost advantage is moderate because scale matters in consumer staples, but Kenvue does not appear to have a clearly superior cost structure versus the strongest peers.

Efficient Scale

Kenvue operates in large, mature consumer categories where national scale can support efficient manufacturing and distribution, but the markets are not naturally monopolistic or capacity-constrained.

The company does not control a scarce asset or regulated bottleneck that would prevent peers from competing effectively, unlike utilities, rail, or certain specialty healthcare channels.

Compared with global consumer staples leaders, Kenvue has meaningful scale but not enough category dominance to make additional entrants uneconomic or to force peer dependence.

Retail channels remain highly competitive and fragmented across mass, grocery, drug, club, and e-commerce, which limits the ability of scale alone to create an efficient-scale moat.

Efficient scale is therefore only modest because the industry can support multiple large competitors without materially eroding Kenvue’s access to customers.

Overall Score

Kenvue’s moat is primarily brand-based and therefore durable enough to support some pricing power and retention, but it is weaker than structural moats because switching costs, network effects, and efficient scale are limited versus peers like P&G, Colgate-Palmolive, and Haleon.